NewInsight: The AI sell-off compared to well-known stock market crashes

Solventum SOLV

Solventum is the 442nd largest S&P 500 company by market cap, worth $15.3 billion. Its board has 12 directors, 11 of them independent. 7 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 10.0% of the company.

CEO
Bryan C. Hanson
Chair
Carrie Smith Cox
Sector
Health CareHealth Care Technology
Headquarters
Saint Paul, Minnesota
Founded
2023
Market cap
$15.3B
442nd largest, 6 Nov 2026 close
Revenue
$8.3B
Fiscal year 2025
Price to sales
1.8
Market cap over revenue
Employees
20,000
10-K, 31 Dec 2025
Per employee
$767K
Market cap over employees
Connections
8
Companies sharing people

Financials

Latest quarter

Second Quarter 2026 figures from Solventum's earnings release.

Filed 5 Aug 2026

Revenue
$2.2B
Up 2.2% year over year
Net income
$92M
Up 2.2% year over year
Diluted EPS
$0.53
Up 3.9% year over year
Operating income
$181M
Down 15% year over year

Reported figures

Figures from the release, against the same period a year earlier.

FigureValueYear earlierChange
Net sales$2.2B$2.2B+2.2%
Gross margin58.2%54.4%+3.8 pts
Operating income$181M$214M-15%
Operating income margin8.2%9.9%-1.7 pts
Net income$92M$90M+2.2%
Diluted earnings per share$0.53$0.51+3.9%
Adjusted diluted earnings per share$2.55$1.69+51%
Free cash flow$144M$59M+144%
Net cash provided by operating activities$227M$169M+34%
Adjusted operating income margin28.4%21.9%+6.5 pts
Adjusted gross margin60.1%56%+4.1 pts

Financial history

Twelve months to 30 Sep 2026, from Solventum's quarterly filings.

Quarters since Mar 2023

Revenue
$8.2B
Down 2.8% on the year before
Net income
$156M
1.9% of revenue
Free cash flow
$0
Operating cash flow less capital spending
P/E
98.3
Market cap over net income

Quarterly results

Each quarter's revenue, net income and free cash flow.

Mar 2023 to Sep 2026

$0$1B$2B$3B2023202420252026$1.9B

Per employee

Twelve months to 30 Sep 2026, over 20,000 employees in Solventum's latest 10-K.

Revenue
$408K
Operating profit
$23K
5.6% of revenue
Net income
$8K
1.9% of revenue

Solventum's market cap since March 2024

Weekly, up to 6 Nov 2026

20252026$15.3B

Board and leadership

Board and officers

7 people here also hold roles at other S&P 500 companies.

Board from the proxy filed 27 Mar 2026; officers filed up to 30 Sep 2026

NameTitleSinceIndependentCommitteesAge
Directors (12)
Carrie Smith CoxChairIndependent · since 2024 · Talent, Science, Technology and QualityExecutive Chairman, Organon & Co.Also at Texas InstrumentsOther boards: Organon & Co.Chair2024YesTalent, Science, Technology and Quality68
Bryan C. HansonChief Executive OfficerNot independent · since 2024Chief Executive Officer2024No59
Carlos AlbanDirectorIndependent · since 2024 · Governance, TalentFormer Vice Chairman, Chief Commercial Officer, AbbVie Inc.Director2024YesGovernance, Talent63
Susan D. DeVoreDirectorIndependent · since 2024 · Governance (chair)Former Chief Executive Officer, Premier Inc.Also at Elevance HealthOther boards: Unum GroupDirector2024YesGovernance (chair)67
Shirley Ann EdwardsDirectorIndependent · since 2024 · Audit, TalentFormer Global Client Service Partner, Ernst & Young Global LimitedAlso at Baker HughesOther boards: Appian Corp.Director2024YesAudit, Talent65
Glenn A. EisenbergDirectorIndependent · since 2024 · Audit (chair)Former EVP and CFO, Laboratory Corporation of America HoldingsOther boards: Middleby, MiniMed and Lumexa Imaging HoldingsDirector2024YesAudit (chair)64
Bernard A. Harris Jr.DirectorIndependent · since 2024 · Governance, Science, Technology and QualityChief Executive Officer and Managing Partner, Versalius Ventures, Inc.Also at RTXOther boards: U.S. Physical TherapyDirector2024YesGovernance, Science, Technology and Quality69
Karen J. MayDirectorIndependent · since 2024 · Talent (chair)Former EVP and CHRO, Mondelez International, Inc.Other boards: AlconDirector2024YesTalent (chair)68
Elizabeth MilyDirectorIndependent · since 2024 · Audit, Science, Technology and QualityChief Executive Officer, The T1D FundDirector2024YesAudit, Science, Technology and Quality58
John H. WeilandDirectorIndependent · since 2024 · Science, Technology and Quality (chair)Former President and COO, C.R. Bard, Inc.Director2024YesScience, Technology and Quality (chair)70
Amy McBride WendellDirectorIndependent · since 2024 · Governance, Science, Technology and QualityFormer SVP of Strategy and Business Development, Covidien plcAlso at Baxter InternationalOther boards: AxoGen and HologicDirector2024YesGovernance, Science, Technology and Quality65
Darryl L. WilsonDirectorIndependent · since 2024 · Audit, TalentPresident, The Wilson CollectiveAlso at Eaton and NextEra EnergyOther boards: PrimericaDirector2024YesAudit, Talent62
Officers (7)
Wayde D. McMillanChief Financial OfficerLast filed 15 May 2026Chief Financial Officer
Tammy L. GomezChief Human Resources OfficerLast filed 15 May 2026Chief Human Resources Officer
Paul S. HarringtonChief Supply Chain OfficerLast filed 15 May 2026Chief Supply Chain Officer
Marcela A. KirbergerChief Legal Affairs OfficerLast filed 15 May 2026Chief Legal Affairs Officer
Heather KnightChief Commercial OfficerAlso at WatersLast filed 9 Mar 2026Chief Commercial Officer
Amy LanducciChief Information OfficerLast filed 15 May 2026Chief Information Officer
Neil Craig ZieselmanSVP, Controller & CAOLast filed 18 Aug 2026SVP, Controller & CAO

Companies that share people with Solventum

Each person's title here, then at the other company.

  • Baker Hughes BKR
    • Shirley Ann Edwards: Director here, Director there
  • Baxter International BAX
    • Amy McBride Wendell: Director here, Director there
  • Eaton ETN
    • Darryl L. Wilson: Director here, Director there
  • Elevance Health ELV
    • Susan D. DeVore: Director here, Director there
  • NextEra Energy NEE
    • Darryl L. Wilson: Director here, Director there
  • RTX RTX
    • Bernard A. Harris Jr.: Director here, Director there
  • Texas Instruments TXN
    • Carrie Smith Cox: Chair here, Director there
  • Waters WAT
    • Heather Knight: Chief Commercial Officer here, Director there

Owners and trading

Largest institutional holders

Each fund group's share of Solventum. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

  • Vanguard10.0%
  • Independent Franchise Partners9.3%
  • BlackRock5.6%
  • Trian Fund Management4.8%
  • Davis Selected Advisers3.6%

These five hold 33.4% of Solventum.

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 6 Nov 2025 to 6 Nov 2026

Directors and officers made no open-market sales and bought $100,344 in 1 purchase in the 12 months to 6 Nov 2026.

DatePersonTitleTypeSharesValue
10 Mar 2026BuyAmy McBride WendellDirectorDirectorBuy1,475$100K

Trades by members of Congress and officials

Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.

Trades from 27 Oct 2023 to 27 Oct 2026

8 people disclosed 12 purchases and 10 sales of Solventum stock since October 2023.

DateMember or officialTypeAmount
1 May 2026Rohit Khanna (House, D-CA)House, D-CA · BoughtPurchase$1,001 to $15,000$1K to $15K
13 Apr 2026Rohit Khanna (House, D-CA)House, D-CA · BoughtPurchase$1,001 to $15,000$1K to $15K
27 Mar 2026Alan Armstrong (Senate, R-OK)Senate, R-OK · BoughtPurchase$1,001 to $15,000$1K to $15K
26 Mar 2026Donald J Trump (President)President · SoldSale$1,001 to $15,000$1K to $15K
17 Mar 2026Donald J Trump (President)President · SoldSale$1,001 to $15,000$1K to $15K
12 Feb 2026Donald J Trump (President)President · BoughtPurchase$1,001 to $15,000$1K to $15K
23 Jan 2026Rohit Khanna (House, D-CA)House, D-CA · SoldSale$1,001 to $15,000$1K to $15K
22 Jan 2026Rohit Khanna (House, D-CA)House, D-CA · SoldSale$1,001 to $15,000$1K to $15K
31 Dec 2025James French Hill (House, R-AR)House, R-AR · SoldSale$15,001 to $50,000$15K to $50K
23 Dec 2025Rohit Khanna (House, D-CA)House, D-CA · BoughtPurchase$1,001 to $15,000$1K to $15K

Showing 10 of 22 trades

Workforce and hiring

Workforce

Headcount at 31 Dec 2025

Employees
20,000
Our employee base consists of approximately 20,000 employees, with approximately 40% having more than 10 years of tenure.
Solventum Form 10-K

Timeline

Leadership changes, layoffs and insider sales

7 Nov 2024 to 7 Nov 2026; insider sales from 6 Nov 2025

2 departures and 2 appointments of directors and officers in the last two years.

Left the company or board 2Appointed 2WARN layoff notices 0Large insider sales 0Jan 2025AprJulOctJan 2026AprJulOct

Events, newest first

Not on file: no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet and no headcount history from earlier 10-Ks.